Skip to content

NKGen Biotech, Inc.

CIK 0001845459

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 Jan 2026
Net Income (TTM)
$478K
+46.6% YoY Q1 Jan 2026
EPS Diluted (TTM)
−$0.81
+71.4% YoY Q1 Jan 2026
Gross Margin
—
Q1 Jan 2026
Operating Margin
—
Q1 Jan 2026
Net Margin
—
Q1 Jan 2026
Free Cash Flow (TTM)
−$12.03M
Q1 Jan 2026
Cash
$6K
Q1 Jan 2026
Total Debt
$5M
Q1 Jan 2026
Shares Outstanding
130.6M sh
Q1 Jan 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings